Archived PandoMedia · Undo
Relay Technology Management
Harnessing Software Analytics to Improve Drug Delivery Efficiency
Product

In the next several years the pharmaceutical industry will hit a wall. The volume of data that must be considered to make informed decisions is increasing at an exponential rate and is becoming overwhelming. Current resources do not adequately aggregate both scientific and market data or enable the level of insight required to transform this complex information into actionable decisions. Relay has developed a software platform, The Relay Innovation Engine, to addresses these issues faced by corporate strategy, intellectual property, business development, licensing, and human resources departments in the biopharma industry. By aggregating data from public and private sources, displaying this information in unique dashboards, and using advanced machine learning algorithms to provide users with actionable insights, The Relay Innovation Engine provide its users increased efficiency and competitive advantages.

Founders
  • Nopic
    Cancel
  • David Greenwald, Ph.D.
    Ph.D. Geneticist with experience in licensing and business development in BioPharma Industry.
  • Nopic
    Unconfirmed
Previous Investors
  • Nopic
    Cancel
  • Doug Redding
    Strategic Financial Advisor to Early-Stage Technology Companies
Advisors
  • Nopic
    Cancel
  • Richard Dale
    Venture Capitalist, Cyclist - hence "Venture Cyclist" http://venturecyclist.blogspot.com
  • Doug Redding
    Strategic Financial Advisor to Early-Stage Technology Companies
  • Paul Bleicher
    Co-founder PhaseForward (Sold to Oracle)
  • Sean Power
    Co-founder BioPharmInsight (Sold to Financial Times)
  • Lawrence Miller
    Founder, Mediphase Ventures & Mednetworks
  • Kenneth I Kaitin
    Director of Tufts Center for Study of Drug Development